The Role of Non-Selective TNF Inhibitors in Demyelinating Events

The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Its use in neurological disorders is limited however, due to rare adverse events of demyelination, even in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Line Buch, Lambertsen, Kate Lykke, Nguyen, Nina, Byg, Keld-Erik, Nielsen, Helle H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824660/
https://www.ncbi.nlm.nih.gov/pubmed/33401396
http://dx.doi.org/10.3390/brainsci11010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824660/
https://www.ncbi.nlm.nih.gov/pubmed/33401396
http://dx.doi.org/10.3390/brainsci11010038

Ejemplares similares